{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:56:08Z","timestamp":1791053768220,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T00:00:00Z","timestamp":1102291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["IRG-77-004-25"],"award-info":[{"award-number":["IRG-77-004-25"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA77764"],"award-info":[{"award-number":["R01 CA77764"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA97274-01"],"award-info":[{"award-number":["P50 CA97274-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immunostimulatory oligodeoxynucleotides (IS ODN) can mediate a number of immunologic effects. We previously demonstrated that treatment of B cell chronic lymphocytic leukemia (B-CLL) cells with one class of IS ODN, CpG ODN, alters their phenotype and increases their immunogenicity. Here, we demonstrate that in contrast to the classic understanding of CpG ODN as inhibitors of B cell apoptosis, IS ODN including CpG ODN induce apoptosis in B-CLL cells. It is important that these changes are seen not only with CpG ODN but with ODN that lack the classical CpG motif. B-CLL cells from 20 subjects were treated in vitro with IS ODN for up to 7 days. IS ODN treatment resulted in increased numbers of apoptotic cells in 13 out of 20 B-CLL samples. IS ODN enhanced apoptosis in samples with 13q deletion as a single aberration and had a heterogeneous effect on apoptosis in samples with other aberrations including 17p deletion, 11q deletion, or trisomy 12. Induction of apoptosis did not correlate with expression of the CpG ODN receptor Toll-like receptor 9. Apoptosis was dependent on the activation of caspases and was accompanied by up-regulation of CD95\/Fas and its ligand. We conclude that IS ODN including CpG ODN can induce apoptosis of most B-CLL samples. The ability of IS ODN to induce apoptosis differs based on cytogenetic status. Up-regulation of CD95\/Fas may play a role in IS ODN-induced apoptosis of B-CLL.<\/jats:p>","DOI":"10.1189\/jlb.0604373","type":"journal-article","created":{"date-parts":[[2004,12,7]],"date-time":"2004-12-07T01:13:21Z","timestamp":1102382001000},"page":"378-387","source":"Crossref","is-referenced-by-count":87,"title":["Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells"],"prefix":"10.1093","volume":"77","author":[{"given":"Bernd","family":"Jahrsd\u00f6rfer","sequence":"first","affiliation":[{"name":"The Holden Comprehensive Cancer Center, University of Iowa , Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E","family":"Wooldridge","sequence":"additional","affiliation":[{"name":"The Holden Comprehensive Cancer Center, University of Iowa , Iowa City"},{"name":"Department of Internal Medicine, University of Iowa , Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue E","family":"Blackwell","sequence":"additional","affiliation":[{"name":"The Holden Comprehensive Cancer Center, University of Iowa , Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana M","family":"Taylor","sequence":"additional","affiliation":[{"name":"The Holden Comprehensive Cancer Center, University of Iowa , Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S","family":"Griffith","sequence":"additional","affiliation":[{"name":"The Holden Comprehensive Cancer Center, University of Iowa , Iowa City"},{"name":"Department of Urology, University of Iowa , Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K","family":"Link","sequence":"additional","affiliation":[{"name":"The Holden Comprehensive Cancer Center, University of Iowa , Iowa City"},{"name":"Department of Internal Medicine, University of Iowa , Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J","family":"Weiner","sequence":"additional","affiliation":[{"name":"The Holden Comprehensive Cancer Center, University of Iowa , Iowa City"},{"name":"Department of Internal Medicine, University of Iowa , Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,12,6]]},"reference":[{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V85.2.307.307","article-title":"Advances in the biology and treatment of B-cell chronic lymphocytic leukemia","volume":"85","author":"O'Brien","year":"1995","journal-title":"Blood"},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.leu.2400598","article-title":"CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules","volume":"11","author":"Van den Hove","year":"1997","journal-title":"Leukemia"},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00262-002-0345-8","article-title":"Melphalan-induced up-regulation of B7\u20131 surface expression on normal splenic B cells","volume":"52","author":"Donepudi","year":"2003","journal-title":"Cancer Immunol. Immunother."},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V100.5.1655.h81702001655_1655_1661","article-title":"Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors","volume":"100","author":"Wendtner","year":"2002","journal-title":"Blood"},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1073\/pnas.022604399","article-title":"Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia","volume":"99","author":"Chu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/cimm.1998.1360","article-title":"Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro","volume":"189","author":"Tretter","year":"1998","journal-title":"Cell. Immunol."},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood.V99.2.722","article-title":"Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia","volume":"99","author":"Anether","year":"2002","journal-title":"Blood"},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1189\/jlb.69.1.81","article-title":"CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens","volume":"69","author":"Jahrsd\u00f6rfer","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1189\/jlb.72.1.83","article-title":"Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN","volume":"72","author":"Jahrsd\u00f6rfer","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0301-472X(00)00144-2","article-title":"Immunostimulatory CpG-oligodeoxynucleotides induce functional high-affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype","volume":"28","author":"Decker","year":"2000","journal-title":"Exp. Hematol."},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V95.3.999.003k10_999_1006","article-title":"Immunostimulatory CpG-oligodeoxynucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells","volume":"95","author":"Decker","year":"2000","journal-title":"Blood"},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/oli.1.1996.6.291","article-title":"Specific suppression of human tumor necrosis factor-\u03b1 synthesis by antisense oligodeoxynucleotides","volume":"6","author":"Hartmann","year":"1996","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of Toll-like receptor 1\u201310 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J. Immunol."},{"key":"2023033023045349100_","first-page":"81","article-title":"Toll-like receptors and their ligands","volume":"270","author":"Barton","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10428190109064586","article-title":"Effect of immunostimulatory CpG-oligodeoxynucleotides in chronic lymphocytic leukemia B cells","volume":"42","author":"Decker","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"2023033023045349100_","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","article-title":"ZAP-70 expression and prognosis in chronic lymphocytic leukaemia","volume":"363","author":"Orchard","year":"2004","journal-title":"Lancet"},{"key":"2023033023045349100_","first-page":"187a","article-title":"Evidence for distinct pathomechanisms in genetic subgroups of CLL by quantitative expression analysis of cell cycle, activation-, and apoptosis-associated genes","volume":"102","author":"Kienle","year":"2003","journal-title":"45. Annual Meeting of the American Society of Hematology"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1189%2Fjlb.0604373","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/77\/3\/378\/49649404\/jlb0378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/77\/3\/378\/49649404\/jlb0378.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T18:32:04Z","timestamp":1682879524000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/77\/3\/378\/6926411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,6]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,12,6]]},"published-print":{"date-parts":[[2004,12,6]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.0604373","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,3]]},"published":{"date-parts":[[2004,12,6]]}}}